香港股市 將在 12 分鐘 開市

Roche Holding AG (RHHVF)

Other OTC - Other OTC 延遲價格。貨幣為 USD。
加入追蹤清單
259.80+4.74 (+1.86%)
收市:03:46PM EST

Roche Holding AG

Grenzacherstrasse 124
Basel 4058
Switzerland
41 61 688 11 11
https://www.roche.com

版塊Healthcare
行業Drug Manufacturers - General
全職員工103,605

高階主管

名稱頭銜支付行使價出生年份
Dr. Severin Schwan Ph.D.Executive Chairman8.53M1967
Dr. Thomas SchineckerChief Executive Officer4.39M1975
Dr. Alan HippeChief Financial & Information Officer4.66M1967
Dr. Bruno EschliHead of Investor Relations
Ms. Claudia BockstiegelGeneral Counsel1964
Ms. Pascale SchmidtChief Compliance Officer1973
Ms. Barbara SchadlerHead of Group Communications1962
Ms. Cristina A. WilburChief People Officer3.32M1967
Dr. Nicolas DunantHead of Group Media Relations
Mr. Boris L. ZaitraHead of Group Business Development and M&A1972
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

公司管治

截至 2024年2月1日 止,Roche Holding AG 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中:8;董事會:6;股東權利:6;現金賠償:7。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。